glutathione and multiple myeloma Frontiers Review on Bortezomib Resistance in
Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies A myeloma targeting monoclonal antibody offers new hope for treating multiple myeloma EurekAlert! Multiple Myeloma Fred & Pamela Buffett Cancer Center University of Nebraska Medical Center Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance Nature Communications
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


